| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -1,563 | 0 |
| Net (decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents | -28,926 | -23,133 |
| Cash and cash equivalents at beginning of period | 78,612 | - |
| Cash and cash equivalents at end of period | 49,686 | - |
Q32 Bio Inc. (QTTB)
Q32 Bio Inc. (QTTB)